393 related articles for article (PubMed ID: 25816130)
1. Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.
Wang G; Zhang X; Yu B; Ren K
Mol Med Rep; 2015 Jul; 12(1):877-84. PubMed ID: 25816130
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation.
Ye X; Huang H; Zhao N; Zhang J; Yang P
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1026-1033. PubMed ID: 27401008
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
[TBL] [Abstract][Full Text] [Related]
4. Growth factor progranulin blocks tumor necrosis factor-α-mediated inhibition of osteoblast differentiation.
Wang N; Zhang J; Yang JX
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706709
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-11-Keto-β-Boswellic Acid Promotes Osteoblast Differentiation by Inhibiting Tumor Necrosis Factor-α and Nuclear Factor-κB Activity.
Bai F; Chen X; Yang H; Xu HG
J Craniofac Surg; 2018 Oct; 29(7):1996-2002. PubMed ID: 29927820
[TBL] [Abstract][Full Text] [Related]
6. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
Lu Z; Wang G; Dunstan CR; Zreiqat H
Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of mechanical strain, icariin and combination stimulations on improving osteoinductive potential via NF-kappaB activation in osteoblast-like cells.
Wang QS; Zhang XC; Li RX; Sun JG; Su WH; Guo Y; Li H; Zhang XZ
Biomed Eng Online; 2015 May; 14():46. PubMed ID: 25994935
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
9. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
[TBL] [Abstract][Full Text] [Related]
10. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
[TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
12. SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway.
Sun H; Wu Y; Fu D; Liu Y; Huang C
Stem Cells; 2014 Jul; 32(7):1943-55. PubMed ID: 24510807
[TBL] [Abstract][Full Text] [Related]
13. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.
Huang H; Zhao N; Xu X; Xu Y; Li S; Zhang J; Yang P
Cell Prolif; 2011 Oct; 44(5):420-7. PubMed ID: 21951285
[TBL] [Abstract][Full Text] [Related]
14. Involvement of p38MAPK/NF-κB signaling pathways in osteoblasts differentiation in response to mechanical stretch.
Wang L; Li JY; Zhang XZ; Liu L; Wan ZM; Li RX; Guo Y
Ann Biomed Eng; 2012 Sep; 40(9):1884-94. PubMed ID: 22441665
[TBL] [Abstract][Full Text] [Related]
15. N-methyl pyrrolidone (NMP) ameliorates the hypoxia-reduced osteoblast differentiation via inhibiting the NF-κB signaling.
Li Q; Liu R; Zhao J; Lu Q
J Toxicol Sci; 2016; 41(5):701-9. PubMed ID: 27665779
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts.
Khan E; Abu-Amer Y
J Lab Clin Med; 2003 Jul; 142(1):29-34. PubMed ID: 12878983
[TBL] [Abstract][Full Text] [Related]
17. Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling.
Ying X; Sun L; Chen X; Xu H; Guo X; Chen H; Hong J; Cheng S; Peng L
Eur J Pharmacol; 2013 Dec; 721(1-3):225-30. PubMed ID: 24076187
[TBL] [Abstract][Full Text] [Related]
18. Sulfated hyaluronan/collagen I matrices enhance the osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone.
Hempel U; Möller S; Noack C; Hintze V; Scharnweber D; Schnabelrauch M; Dieter P
Acta Biomater; 2012 Nov; 8(11):4064-72. PubMed ID: 22771456
[TBL] [Abstract][Full Text] [Related]
19. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
[TBL] [Abstract][Full Text] [Related]
20. Extracellular calcium chronically induced human osteoblasts effects: specific modulation of osteocalcin and collagen type XV.
Gabusi E; Manferdini C; Grassi F; Piacentini A; Cattini L; Filardo G; Lambertini E; Piva R; Zini N; Facchini A; Lisignoli G
J Cell Physiol; 2012 Aug; 227(8):3151-61. PubMed ID: 22034088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
